Ocular Discomfort Assessment After Intravitreal Injections

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

July 1, 2017

Conditions
Macular DegenerationDiabetic RetinopathyRetinal Artery OcclusionMyopia, Degenerative
Interventions
DRUG

Optive

Optive eye drops will be prescribed to each included patients after their second intravitreal injection; patients will received 1 drop in the affected eye 2 times a day during 3 days

Trial Locations (1)

94000

Chi Creteil, Créteil

All Listed Sponsors
lead

Centre Hospitalier Intercommunal Creteil

OTHER

NCT02806830 - Ocular Discomfort Assessment After Intravitreal Injections | Biotech Hunter | Biotech Hunter